safety

August 20, 2018August 20, 2018

Remicade at Higher Than Usual Doses Seen as Effective and Safe in Controlling Inflammation in IBD Patients

News

Higher doses of Remicade (infliximab) can ease the symptoms of inflammatory bowel disease (IBD) by better controlling inflammation with raising the risk of adverse effects — like more infections — in patients, ... Read more

June 9, 2016August 12, 2016

IBD Study Shows Celltrion’s Inflectra, Biosimilar of Infliximab, Is Safe and Effective

Crohn's Disease, IBD News, News, Ulcerative colitis

Celltrion’s Inflectra, a biosimilar version of infliximab (Remicade), is both safe and effective in patients with inflammatory bowel disease (IBD), a recent study reported at the Digestive Disease Week 2016 meeting ... Read more

March 10, 2016March 10, 2016

Use of Glutamine in Crohn’s Disease Needs More Evaluation, Review Finds

News

A review published by the The Cochrane Library reported that there is not enough evidence to draw conclusions about the efficacy and safety of glutamine for inducing remission in patients with Crohn’s ... Read more

March 4, 2016March 4, 2016

Patients with Crohn’s and Ulcerative Colitis Show Promising Results in Entyvio Clinical Trials

News

Recently compiled safety data from all clinical trials on Entyvio (vedolizumab) for patients with inflammatory bowel disease (IBD) show the drug is associated with low rates of new serious infections, infusion-related reactions, and cancers. ... Read more